Viad - VVI Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Viad in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" VVI shares.
View VVI analyst ratings or view top-rated stocks.

1 brokerages have issued 1-year target prices for Viad's stock. Their VVI share price forecasts range from $42.00 to $45.00. On average, they anticipate the company's stock price to reach $43.50 in the next twelve months. This suggests a possible upside of 122.4% from the stock's current price.
View analysts price targets for VVI or view top-rated stocks among Wall Street analysts.

Viad's stock was trading at $24.39 at the start of the year. Since then, VVI shares have decreased by 19.8% and is now trading at $19.56.
View the best growth stocks for 2023 here.

Viad saw a increase in short interest in February. As of February 28th, there was short interest totaling 405,400 shares, an increase of 16.6% from the February 13th total of 347,800 shares. Based on an average daily volume of 128,300 shares, the days-to-cover ratio is currently 3.2 days. Currently, 2.0% of the shares of the stock are sold short.
View Viad's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our VVI earnings forecast.

Viad Corp (NYSE:VVI) announced its quarterly earnings results on Thursday, November, 4th. The business services provider reported $0.58 earnings per share for the quarter, missing the consensus estimate of $1.75 by $1.17. The business services provider had revenue of $233.60 million for the quarter, compared to analyst estimates of $150.27 million. Viad had a trailing twelve-month return on equity of 14.52% and a net margin of 2.24%. During the same quarter last year, the firm earned ($0.81) EPS.

ETFs with the largest weight of Viad (NYSE:VVI) stock in their portfolio include Invesco S&P SmallCap Industrials ETF (PSCI).

5 employees have rated Viad Chief Executive Officer Steve W. Moster on Glassdoor.com. Steve W. Moster has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Viad investors own include Pfizer (PFE), AbbVie (ABBV), Verizon Communications (VZ), Dynavax Technologies (DVAX), Enbridge (ENB), Procter & Gamble (PG), QUALCOMM (QCOM), Trevena (TRVN), Universal Technical Institute (UTI) and VBI Vaccines (VBIV).

Viad trades on the New York Stock Exchange (NYSE) under the ticker symbol "VVI."

Viad's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (9.69%), Victory Capital Management Inc. (9.69%), Victory Capital Management Inc. (9.66%), Blue Grotto Capital LLC (6.40%), Allspring Global Investments Holdings LLC (6.39%) and River Road Asset Management LLC (6.28%). Insiders that own company stock include Andrew B Benett, Ellen M Ingersoll, Jeffrey A Stelmach, Joshua Schechter and Steven W Moster.
View institutional ownership trends.

Shares of VVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VVI stock can currently be purchased for approximately $19.56.

Viad (NYSE:VVI) has a market capitalization of $405.67 million and generates $1.13 billion in revenue each year. The business services provider earns $23.22 million in net income (profit) each year or $0.12 on an earnings per share basis.

The company employs 3,387 workers across the globe.

Viad's mailing address is 1850 NORTH CENTRAL AVENUE SUITE 1900, PHOENIX AZ, 85004. The official website for the company is www.viad.com. The business services provider can be reached via phone at (602) 207-1000, via email at investorrelations@viad.com, or via fax at 602-207-5834.